|
CCDC18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7069012869797E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.90410001496855E-09 |
| Normal-vs-Stage2 |
5.644000E-03 |
| Normal-vs-Stage3 |
3.684900E-03 |
| Normal-vs-Stage4 |
7.400100E-03 |
| Stage1-vs-Stage2 |
6.839600E-01 |
| Stage1-vs-Stage3 |
6.921000E-01 |
| Stage1-vs-Stage4 |
4.441000E-01 |
| Stage2-vs-Stage3 |
5.704200E-01 |
| Stage2-vs-Stage4 |
3.025800E-01 |
| Stage3-vs-Stage4 |
6.460800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.57639465317538E-11 |
| Normal-vs-AfricanAmerican |
1.57343999999116E-05 |
| Normal-vs-Asian |
1.053190E-01 |
| Caucasian-vs-AfricanAmerican |
5.001200E-01 |
| Caucasian-vs-Asian |
3.422000E-01 |
| AfricanAmerican-vs-Asian |
3.006400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90079951778444E-10 |
| Normal-vs-Female |
1.81779999941512E-08 |
| Male-vs-Female |
2.736000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.10530000000131E-05 |
| Normal-vs-Extreme_Weight |
6.50989999684271E-08 |
| Normal-vs-Obese |
2.51719999955213E-07 |
| Normal-vs-Extreme_Obese |
5.004000E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.276600E-01 |
| Normal_Weight-vs-Obese |
5.941600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.023600E-01 |
| Extreme_Weight-vs-Obese |
7.986000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.304200E-01 |
| Obese-vs-Extreme_Obese |
9.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.70999999999211E-05 |
| Normal-vs-Age(41-60Yrs) |
2.90839574645929E-11 |
| Normal-vs-Age(61-80Yrs) |
2.6944000031115E-08 |
| Normal-vs-Age(81-100Yrs) |
9.143800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.736190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.051900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.639800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.568990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.035700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.772580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.58848498191355E-12 |
| Normal-VS-Type2 PRCC |
8.903800E-03 |
| Normal-VS-KIRP CIMP |
2.08079999999278E-05 |
| Normal-VS-Unclassified PRCC |
3.65270000000084E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.756100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.124000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.456800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.771430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.260200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.949600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.20510000000074E-05 |
| Normal-vs-N1 |
3.407500E-04 |
| Normal-vs-N2 |
3.152400E-01 |
| N0-vs-N1 |
3.681000E-01 |
| N0-vs-N2 |
5.722400E-01 |
| N1-vs-N2 |
6.885000E-01 |
|
|
